Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers

Digestive Surgery

Volumn 29, Issue 6, 2012, Pages 522-528

  Witjes, Caroline D M ^a   Polak, Wojciech G ^a   Verhoef, Cornelis ^a   Eskens, Ferry A L M ^a   Dwarkasing, Roy S ^a   Verheij, Joanne ^a   De Man, Robert A ^a   Ijzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hepatocellular carcinoma; Liver; Non cirrhotic liver; Non viral factors; Risk factors; Survival

Indexed keywords

EID: 84875655556     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000348669     Document Type: Article

References (24)

1. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of he-patocellular carcinoma: an update. Hepatology 2011; 53:1020-1022.
2. Taylor-Robinson SD, Foster GR, Arora A, Hargreaves S, Thomas HC: Increase in primary liver cancer in the UK, 1979-94. Lancet 1997; 350:1142-1143. (Pubitemid 27454010)
3. Deuffic S, Poynard T, Buffat L, Valleron AJ: Trends in primary liver cancer. Lancet 1998; 351:214-215.
4. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-750. (Pubitemid 29114292)
5. Witjes CDM, Karim-Kos HE, Visser O, van den Akker SAW, de Vries E, Ijzermans JNM, et al: Hepatocellular carcinoma in a low endemic area: rising incidence and improved survival. Eur J Gastroenterol Hepatol 2012; 24: 450-457.
6. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJC, Tilanus HW, Ijzermans JNM: Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2004; 21:380-386. (Pubitemid 40458693)
7. Nzeako UC, Goodman ZD, Ishak KG: Hepatocellular carcinoma in cirrhotic and noncir-rhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996; 105:65-75.
8. Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, et al: Etiologic factors and clinical presentation of hepatocel-lular carcinoma. Differences between cirrhot-ic and noncirrhotic Italian patients. Cancer 1995; 75:2220-2232.
9. Van Roey G, Fevery J, van Steenbergen W: Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients. Eur J Gastoenterol Hepatol 2000; 12:61-66. (Pubitemid 30072106)
10. Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein C, et al: Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver 2000; 20:312-318. (Pubitemid 30488002)
11. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H, et al: Prognostic factors and survival after hepatic resection for hepa-tocellular carcinoma without cirrhosis. Br J Surg 2001; 88:515-522. (Pubitemid 32291231)
12. Alkofer B, Lepennec V, Chice L: Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg 2001; 148:3-11.
13. Statistics Netherlands: Healthcare use and hospital admission statistics in the Netherlands. http://statline.cbs.nl/StatWeb/selection/?DM=SLNL&PA= 71860NED&VW=T (accessed April 24, 2009).
14. Lauwers GY, Terris B, Balis UJ, Batts KP, Regimbeau JM, Chang Y, et al: Prognostic his-tologic indicators of curatively resected hepa-tocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002; 26:25-34. (Pubitemid 34019989)
15. Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, et al: Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg 2011; 98:697-703.
16. Lubrano J, Huet E, Tsilividis B, François A, Goria O, Riachi G, et al: Longterm outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 2008; 22:104-109. (Pubitemid 50003884)
17. Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF: Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at time of resection. Am J Gastroenterol 2008; 103:1663-1673.
18. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M: Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42:341-347.
19. Mergental H, Porte J: Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transplant Int 2010; 23:662-667.
20. Lang H, Sotiropoulos GC, Dömland M, Früh-auf NR, Paul A, Hüsting J, et al: Liver resection for hepatocellular carcinoma in non-cir-rhotic liver without underlying viral hepatitis. Br J Surg 2005; 92:198-202. (Pubitemid 40269334)
21. Giannini EG, Farinati F, Trevisani F: Alphafetoprotein in hepatocellular carcinoma surveillance: wake not the dead. Hepatology 2011; 1:367-377.
22. Mergental H, Adam R, Ericzon BG, Kalicinski P, Mühlbacher F, Höckerstedt K, et al: Liver transplantation for unresectable hepatocellu-lar carcinoma in normal livers. J Hepatol 2012; 57:297-305.
23. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Montalto F, et al: Liver transplantation for the treatment of small hepato-cellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
24. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, et al: Assessment of genetic changes in hepatocellular carcinoma by comparative ge-nomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999; 154:37-43. (Pubitemid 29031609)